Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Nothing for shareholders
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Comment by Breakthorough1on Aug 17, 2023 12:46am
162 Views
Post# 35592278

RE:RE:RE:RE:Nothing for shareholders

RE:RE:RE:RE:Nothing for shareholdersWhat I really don't understand. If the stay period is extended till September 29, knowing that the whole Stage1 of Lymphoma will pass the second scan around September 20th, and being only 9 pstients on treatment. Why not to wait till september to wind down the trials? Why not to wait a bit more and disclose the results? Were not them suppose to add to "the growing enthusiams" about DPX in Lymphoma they have mentioned so many times? 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities